Wednesday, September 17, 2014

Actavis - Bets Bet in Drug Sector

http://seekingalpha.com/article/2501335-actavis-is-the-best-bet-in-the-drug-sector

Summary

  • Analysts predict aggressive growth in both revenue and earnings.
  • 96% of the analysts following the company rate it Buy or better.
  • Highly rated by both Barchart and Value Line.
Posted by Jim Van Meerten at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)